BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24434344)

  • 1. Targeted vascular drug delivery. A new day for an old way.
    Buchbinder M; Solar R
    Panminerva Med; 2013 Dec; 55(4):353-61. PubMed ID: 24434344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

  • 3. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
    Byrne RA; Kastrati A
    EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local drug delivery for treatment of coronary and peripheral artery disease.
    Gertz ZM; Wilensky RL
    Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 8. New technologies in percutaneous coronary interventions: drug-coated balloons.
    Kleber FX; Scheller B; Serruys PW
    EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.
    Abergel E; Beyar R; Roguin A
    Cardiovasc Revasc Med; 2013; 14(2):106-8. PubMed ID: 23195308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From bench to Paccocath.
    Cremers B; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K23-31. PubMed ID: 22027724
    [No Abstract]   [Full Text] [Related]  

  • 11. In-stent restenosis: the gold standard has changed.
    Chin K
    EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEVO™: a new generation of sirolimus-eluting coronary stent.
    Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
    EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology.
    Cortese B; Berti S; Biondi-Zoccai G; Colombo A; Limbruno U; Bedogni F; Cremonesi A; Silva PL; Sgueglia GA;
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):427-35. PubMed ID: 23934956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Results of Drug-Coated Balloons for Drug-Eluting In-Stent Restenosis: Gaining Perspective.
    Alfonso F; Cuesta J
    JACC Cardiovasc Interv; 2015 Jun; 8(7):885-8. PubMed ID: 26003025
    [No Abstract]   [Full Text] [Related]  

  • 17. 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO).
    Latib A; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1132-1134. PubMed ID: 26205451
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study.
    Belkacemi A; Agostoni P; Voskuil M; Stella PR
    EuroIntervention; 2011 May; 7 Suppl K():K66-9. PubMed ID: 22027731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 20. How to use the drug-eluting balloon: recommendations by the German consensus group.
    Kleber FX; Mathey DG; Rittger H; Scheller B;
    EuroIntervention; 2011 May; 7 Suppl K():K125-8. PubMed ID: 22027722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.